Tecovirimat Powder Cas No.869572-92-9
Product Source: Synthetic
Product Specification: ≥98%
CAS No.: 869572-92-9
Molecular Formula: C₁₉H₁₅F₃N₂O₃
Molecular Weight: 376.33 g/mol
Test Method: HPLC
Active Ingredient: Tecovirimat
Product Characteristics: White to off-white powder
Product Packaging: 1kg/bag; 25kg/drum
Storage Conditions: Store in light-protected, inert atmosphere at room temperature
Shelf Life: 24 months
Declaration of Use: This product is intended for industrial use or scientific research only.
Products Description
Xi'an Tihealth High-Purity Tecovirimat API
We supply ultra-high-purity Tecovirimat (Tecovirimat) active pharmaceutical ingredient (API). Produced using advanced synthesis technology and rigorously controlled via HPLC and other analytical methods, this product maintains stable active ingredient purity ≥98%, ensuring exceptional consistency and reliability. We focus on meeting core requirements for antiviral drug R&D and manufacturing. All processes adhere to stringent quality control systems, providing safe, pure, and compliant raw materials for your critical formulation development, clinical studies, and commercial production.
This product is strictly differentiated from reagent-grade materials intended solely for research purposes. From the outset, it adheres rigorously to API quality control requirements, committed to providing customers with top-tier raw materials directly applicable for pharmaceutical use. Our Tecovirimat API serves as the solid foundation for building your core competitiveness. Please inquire for detailed Certificates of Analysis (COA) and customized solutions.
Products Function
Tecovirimat is a potent antiviral agent specifically designed to inhibit the replication of orthopoxviruses. It functions by selectively targeting and disrupting viral spread within the host, making it a critical component in the treatment of poxvirus infections.
Products Application
This high-purity Tecovirimat API is primarily used in the pharmaceutical development and manufacturing of antiviral drugs aimed at treating infections caused by orthopoxviruses, including monkeypox, smallpox, and cowpox. It is suitable for formulation into various dosage forms such as oral capsules and injectables, supporting both clinical development and commercial production in compliance with global regulatory standards.
Mechanism of Action
Tecovirimat exerts its antiviral effect by selectively targeting the viral VP37 protein (also known as p37), which is encoded by orthopoxviruses. By binding strongly to VP37, it disrupts the formation of the envelope that surrounds mature virus particles. This inhibition prevents the release and subsequent spread of infectious virions from infected cells, effectively containing viral replication and reducing disease progression.
Hot Tags: tecovirimat powder cas no.869572-92-9, China tecovirimat powder cas no.869572-92-9 manufacturers, suppliers, factory
You Might Also Like
Send Inquiry